Screening for variable drug responses using human iPSC cohorts
Preprint
Abstract
We have developed a laboratory-based drug screening platform that uses a cohort of human induced pluripotent stem cell (hiPSC) lines, derived from different donors, to predict variable drug responses of potential clinical relevance. This builds on recent findings that pluripotent hiPSC lines express a broad repertoire of gene transcripts and proteins, whose expression levels reflect the genetic identity of the donor. We demonstrate that a cohort of hiPSC lines from different donors can be screened efficiently in their pluripotent state, using high-throughput Cell Painting assays. Variable phenotypic responses between hiPSC lines were detected with a wide range of clinically approved drugs, in use across multiple disease areas. Furthermore, information on mechanisms of drug-cell interactions underlying the observed variable responses was derived by using quantitative proteomic analysis to compare sets of hiPSC lines that had been stratified objectively, based upon variable response, Cell Painting data. We propose that information derived from comparative drug screening, using curated libraries of hiPSC lines from different donors, can help to improve the delivery of safe new drugs suitable for a broad range of genetic backgrounds and sexual diversity within human populations.Keywords
All Related Versions
- Published version: PLOS ONE, 20 (5), e0323953.
This publication has 67 references indexed in Scilit:
- Induced pluripotent stem cells in medicine and biologyDevelopment, 2013
- A Review of the Methods for Human iPSC Derivation2013
- OMERO: flexible, model-driven data management for experimental biologyNature Methods, 2012
- A novel statin-mediated “prenylation block-and-release” assay provides insight into the membrane targeting mechanisms of small GTPasesBiochemical and Biophysical Research Communications, 2010
- APOE gene polymorphisms and response to statin therapyThe Pharmacogenomics Journal, 2009
- Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin bindingThe FEBS Journal, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteinsMolecular Psychiatry, 2003
- Structural Mechanism for Statin Inhibition of HMG-CoA ReductaseScience, 2001
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988